Prediction of therapeutic efficacy of infliximab for refractory ulcerative colitis by analyzing and measuring serum concentration of cytokines and infliximab
Not Applicable
- Conditions
- lcerative colitis
- Registration Number
- JPRN-UMIN000010205
- Lead Sponsor
- School of Medicine, Keio University Division Gastroenterology and Hepatology, Department of Internal Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who refuse the induction infliximab therapy or those who don't agree with participating in this study after sufficient written explanation.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method